Krystal Biotech’s $200 Million Rights Offering

Martina Bellini
Tagged:

Morrison & Foerster advised Krystal Biotech on the deal.Krystal Biotech, Inc. announced its $200 million common stock offering at $75 per share. Goldman Sachs & Co. LLC,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now